Researchers Find Telemedicine may Help Reduce Use of Unnecessary Health Tests

Low-value care - medical tests and procedures that provide little to no benefit to patients - contributes to excess medical spending and both direct and cascading harms to patients. A research team from Mass General Brigham and their collaborators have found that telemedicine may help to reduce the use of low-value tests. The work is published in JAMA Internal Medicine.

"In theory, widespread adoption of telemedicine post-pandemic may influence low-value testing - such as Pap smears and prostate cancer screenings in older adults, and imaging scans for straightforward cases of low back pain," said lead author Ishani Ganguli, MD, MPH, of the Division of General Internal Medicine and Primary Care at Brigham and Women’s Hospital, a founding member of Mass General Brigham, and an Associate Professor of Medicine at Harvard Medical School. "But there was very limited evidence on this. We wanted to look at this question at a national level because there is active policy debate about whether and how Medicare should continue telemedicine coverage, hinging in large part on how telemedicine impacts care quality and spending."

Using a quasi-experimental study design, Ganguli and her colleagues analyzed 2019–2022 fee-for-service Medicare claims data from more than 2 million beneficiaries who received their care in health systems across the United States that either did or did not adopt telemedicine at high rates during the COVID-19 pandemic. This timeframe encompassed the time before and after telemedicine use skyrocketed with the pandemic.

Compared to patients in low-telemedicine systems, patients in high-telemedicine systems had slightly higher rates of total visits (including virtual or in-person) and lower use of 7 of 20 low-value tests: cervical cancer screening, screening electrocardiograms, screening metabolic panels, preoperative complete blood cell counts, preoperative metabolic panels, total or free triiodothyronine level testing for hypothyroidism, and imaging for uncomplicated low back pain. There were no significant differences in other tests. Those in high-telemedicine systems had lower spending on visits per beneficiary and on 2 of 20 low-value tests, but no differences in low-value spending overall.

The findings suggest that while virtual options may reduce barriers to care, telemedicine may also deter clinicians and patients from completing some low-value tests, especially tests like electrocardiograms and blood counts that would be done on-site during or just after an office visit.

"These findings offer further reassurance to policymakers that extending telemedicine coverage may carry benefits like lower use and spending on a number of low-value tests," said Ganguli.

Ganguli I, Lim C, Daley N, Cutler D, Rosenthal M, Mehrotra A.
Telemedicine Adoption and Low-Value Care Use and Spending Among Fee-for-Service Medicare Beneficiaries.
JAMA Intern Med. 2025 Feb 24:e248354. doi: 10.1001/jamainternmed.2024.8354

Most Popular Now

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...